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SUMMARY
This is the first attempt to systematically record haematological malignancies in Northern Ireland.
The methods are identical to a similar effort in other parts ofthe UK,' except that an independent
crosscheckwithacancerregistrysource wasnotpossible. Inadditionproblemswiththecensusmay
create differences. Generally, the rates for the leukaemias are slightly lower than in England and
Wales, exceptforacutelymphoblastic leukaemia whilstnon-Hodgkin'slymphoma rates arehigher.
It remains to be seen how stable this situation is as further data are accumulated.
INTRODUCTION
The Northern Ireland Leukaemia Research Fund
Data Collection Study started in 1989 as an
independent collection system. At that time there
was no Health Service cancer registration scheme
inNorthernIreland. Theaimwastogiveanaccurate
picture of the descriptive epidemiology of
haematological malignancies in Northern Ireland.
Thedatacomefromaspecialcollectionofmaterial
from the diagnostic laboratories of collaborating
haematologists and histopathologists around the
province. Themethodofcollectionwasthesameas
that used in parts of Great Britain.' A previously
published study in Northern Ireland2 (the Podar
report) concentrated on those leukaemias which
are associated with ionising radiation, and used
several incomplete registration sources to
retrospectively obtain incident cases.
Using these data, variations in the incidence of
diseaseby age, sex and areacan bedescribed. This
is of intrinsic interest and may also be of value in
generating hypotheses about the causes of the
diseases studied.
Incidenceratherthandeathcertificatedataareused
because there is concern overboth the accuracy of
deathcertificates and theirvalidity as a measure of
disease incidence. Therapeutic advances have led
to marked changes in the survival pattern of both
leukaemias and lymphomas, with greater survival
ratesleadingtomarkeddeclineinmortality.3Death
certificates were used in the Podar report2 to
examine mortality in the leukaemias linked with
ionising radiation.
METHODS: Background
Seven disease groupings were used, namely:-
(1) Acute Myeloid Leukaemia (AML),
(2) Chronic Myeloid Leukaemia (CML),
(3) Myelodysplasia (MDS),
(4) Acute Lymphoblastic Leukaemia (ALL),
(5) Non-Hodgkin's Lymphoma (NHL),
(6) Hodgkin's disease (HD), and
(7) Multiple Myeloma (MM).
Thesegroupingswerechosenbecausetheyprovided
sufficient numbers ofcases for acritical statistical
analysis.
Incidencedataarereportedin5-yearagegroupsup
to 79 years.4 In common with the GB Leukaemia
ResearchFundatlas,' noincidencedataontheover
80's are reported because of lack of diagnostic
accuracyandascertainmentproblems.Furtherdetail
is given in the full report.4
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Local government district populations from the
1991 census were used in the analysis.5 However,
since no post-enumeration survey was carried out,
the quality of data is likely to be poor in certain
areas and certain age-groups due to under-
enumeration.6
METHODS: Data Collection
Hospitalslikelytodiagnoseortreathaematological
malignancies were identified and the help oftheir
haematologists and histopathologists sought. A
centralhospital ineach areawhoseconsultant staff
were prepared to oversee the activity of a Belfast
based,NorthernIrelandLeukaemiaResearchFund
funded clerical officer, was identified. The clerk's
duty was to collect and record information on
everynewcasefallingwithintheagreeddiagnostic
groups presenting at the hospitals. Each clerk had
a limited number of hospitals to visit to collect
data. This wasrecordedonstandardforms andwas
completedforallnewregistrationsafter 1stJanuary,
1989. Included for each patient were full name,
sex, date of birth, home address and postcode at
diagnosis, exact diagnosis and the date it was
made. Copies of relevant haematology or
histopathology reports were sent with the
registration form to theLeukaemiaResearch Fund
centre in Leeds. All the haematologists and
histopathologistsinNorthernIrelandwereinvolved
in this study.
Theexact system forcase identification fromeach
hospital laboratory was adapted to local practices
relating to the reporting and storage ofdiagnostic
information. Wheneverthere was doubtregarding
the validity of a registration, the information was
senttoLeeds foradecision. In additionthe returns
made by each clerk were relayed back for
subsequent rechecking and for the addition of
missingdata.Theworkofthedatacollectionclerks
was controlled by regular contact with Leeds.
Also, detailed procedures have been compiled
hospital by hospital and kept up to date.
On receipt, the identification information was
checked and the address postcode confirmed. A
matching and identification program enabled the
personal details to be checked to discover if the
patienthadbeenregistered already. Ifnot, orifthe
previous registration related to another diagnosis,
theregistrationwascompleted. Aseconddiagnosis
was normally registered only if a malignant
progression appeared to be ruled out.
The computer software has numerous logical
checks. Also, all new input data are proofread by
two clerks. Cases with missing information are
reviewed, duplicate registrations are checked for
discrepant information and decisions about
registration made.
Unfortunately, as there was no formal cancer
registration scheme in Northern Ireland when the
study was setup ithas notbeen possible toperform
cross-checking for this time period.
STATISTICAL ANALYSIS
Sincecancerincidenceratesshowmarkedvariation
with age and sex, it is necessary to standardise the
rates so as to ensure that regional differences are
notmerelyareflectionofdifferencesintheage-sex
structure of the population. In computing figures
for the entire Northern Ireland study area (see
Tables 1, 2 and Figures 1 of the full report4), the
direct method of standardisation has been used,
andoverallincidenceratesstandardisedtoauniform
population are presented.
Elsewhereinthefullreport,4indirectstandardisation
isused,becauseweareseekingtomakecomparisons
betweenthe26NorthernIrelanddistricts, andsuch
comparisonsaresubjecttosmallerrandomvariation
when this method is used. Age-sex specific rates
fortheentireareaofNorthernIrelandarecomputed
andusedtogenerateexpectednumbersofcases for
each district. The ratio ofobserved to expected for
the district is its Standardized Morbidity Ratio
(SMR), which is given as a percentage.
AdistrictwithanSMRof 100hasthesamenumber
of cases as if the provincial age and sex-specific
rates had applied. Any process of computing a
standardised ratio involves calculating an average
oftheratiosapplicabletoindividualage-sex strata.
Thiswillnotbeappropriateifgeographicalchanges
of risk themselves show age or sex variation.
Differencesbetweentheobservedcasecounts, and
the expected values are reported in terms of "p-
values".4
If age-standardised rates, or SMR's, are mapped,
then there is a tendency for those areas with few
events to yield extreme values owing to Poisson
variation. These areas are then given undue
prominence. One proposed solution is to include
some measure of statistical significance in the
information to be mapped.7 Indeed, most atlases
have exclusively mapped p-values. However, this
confuses statistical significance with biological
importanceandgivesundueprominencetoareasof
high population in which quite modest deviations
of the rate from the overall value may achieve a
high level of statistical significance.
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TABLE I
Age-specific incidence rates and uniformn standardised incidence rates (per 100,000 person years) by
disease grouping, pooled over both sexes. The number ofcases is in parentheses.
Age AML CML MDS ALL NHL HD MM
0-4 1.4 (9) 0.0 (0) 0.0 (0) 7.4 (47) 1.3 (8) 0.0 (0) 0.0 (0)
5-9 0.2 (1) 0.0 (0) 0.0 (0) 2.9 (19) 0.0 (0) 0.9 (6) 0.0 (0)
10-14 0.6 (4) 0.5 (3) 0.2 (1) 1.7 (11) 0.3 (2) 0.6 (4) 0.0 (0)
15-19 0.8 (5) 0.0 (0) 0.2 (1) 1.9 (12) 1.1 (7) 2.2 (14) 0.0 (0)
20-24 1.1 (7) 0.2 (1) 0.0 (0) 0.6 (4) 1.1 (7) 2.9 (18) 0.0 (0)
25-29 0.8 (5) 0.0 (0) 0.2 (1) 0.5 (3) 1.3 (8) 2.5 (15) 0.0 (0)
30-34 1.2 (7) 0.4 (2) 0.2 (1) 0.7 (4) 0.9 (5) 3.2 (18) 0.2 (1)
35-39 1.0 (5) 0.4 (2) 0.4 (2) 0.6 (3) 2.4 (12) 1.2 (6) 0.8 (4)
40-44 1.6 (8) 0.4 (2) 0.4 (2) 0.2 (1) 5.9 (29) 2.0 (10) 0.2 (1)
45-49 1.1 (5) 0.2 (1) 0.4 (2) 0.2 (1) 9.8 (44) 1.1 (5) 2.9 (13)
50-54 1.6 (6) 1.3 (5) 1.3 (5) 0.3 (1) 13.3 (51) 1.3 (5) 2.9 (11)
55-59 4.5 (16) 2.5 (9) 2.0 (7) 0.0 (0) 16.0 (57) 1.7 (6) 5.6 (20)
60-64 4.6 (16) 0.9 (3) 5.3 (18) 1.2 (4) 22.8 (79) 2.6 (9) 10.7 (37)
65-69 7.4 (24) 0.9 (3) 10.5 (34) 1.2 (4) 34.8 (113) 3.1 (10) 11.7 (38)
70-74 4.6 (12) 1.2 (3) 15.0 (39) 1.2 (3) 37.2 (97) 0.8 (2) 21.1 (55)
75-79 8.4 (17) 0.5 (1) 18.9 (38) 0.0 (0) 45.7 (92) 2.5 (5) 21.8 (44)
Uniform 2.6 (147) 0.6 (35) 3.4 (151) 1.3 (117) 12.1 (611) 1.8 (133) 4.9 (224)
Standardised
Rate
A compromise is an "empirical Bayes") version of
the SMR.8 A probability model is adopted for the
prior distribution of the true relative risks across
the map. The influence of this model upon the
estimationoftherelativerisksfollowsfrom"Bayes
theorem"".Themethodforestimatingtheparameters
of this prior distribution is termed the "empirical
Bayes" method
Two types ofmap are illustrated in the full report.4
Both use "empirical Bayes" methods.8 The first is
a map of relative risk (RR) estimates which lie
intermediate between the area-specific SMR and
the mean of all the age-adjusted relative risks
included in the map. Estimates are shrunk towards
the mean; this shrinkage is substantial for RR's
based upon small numbers of events while those
based upon large numbers remain close to the
corresponding SMR's. Using small areas, this
approach may be modified so that shrinkage is
towards a"local" mean based upon adjacentareas,
and this method was used in the second map.4
Comprehensiveresults aregiveninthefullreport.4
GENSTAT V was used to carry out all analyses.9
RESULTS AND DISCUSSION
ACUTE MYELOID LEUKAEMIA
Therewere 147cases.Age-specificincidencerates
show higher rates in the first five years, followed
by a decline (Table I). The pooled rates do not
exceedthoseobservedincasesaged0-4yearsuntil
the 40's. There is a female excess in those aged 5-
35yearsroughlysimilarratesinbothsexesbetween
35 and55 yrs and amalepredominance emerges in
the over 55's. There is no evidence for a temporal
trend. There is no evidence for between-district
heterogeneity inthe SMR's (Table II). There is not
much variation in the "shrunk" RR's.
However, for the adjacency smoothed RR's, the
highest rates tend to be concentrated in the South
East of the province, particularly in the County
Down area, Belfast Lough and the Mourne
mountains. The lowest rates occur in the north of
the province, and County Fermanagh.
CHRONIC MYELOID LEUKAEMIA
There were 35 cases. Age-specific incidence rates
(Table I) show afemale excess in the under20's, a
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TABLE II
SMR's by district ofresidence and disease grouping, pooled over both sexes. The number of
cases is in parentheses. Significantly high or low SMR's are indicated by stars.'0
District AML CML MDS ALL NHL HD MM
Derry 116 (9) 106 (2) 147 (10) 87 (7) 115 (34) 103 (8) 88 (9)
Limavady 124 (3) 358 (2) 188 (4) 42 (1) 55 (5) 122 (3) 94 (3)
Coleraine 63 (3) 173 (2) 20 (1)* 56 (2) 108 (22) 117 (5) 80 (6)
Ballymoney 88 (2) 0 (0) 0 (0) 56 (1) 63 (6) 196 (4) 58 (2)
Moyle 0 (0) 0 (0) 0 (0) 0 (0) 50 (3) 0 (0) 88 (2)
Lame 139 (4) 0 (0) 33 (1) 148 (3) 89 (11) 40 (1) 88 (4)
Ballymena 75 (4) 0 (0) 109 (6) 50 (2) 102 (23) 84 (4) 145 (12)
Magherafelt 32 (1) 0 (0) 32 (1) 69 (2) 95 (12) 167 (5) 108 (5)
Cookstown 111 (3) 0 (0) 112 (3) 119 (3) 120 (13) 118 (3) 172 (8)
Strabane 95 (3) 0 (0) 164 (5) 35 (1) 79 (10) 101 (3) 154 (7)
Omagh 125 (5) 108 (1) 227 (9)* 82 (3) 88 (14) 80 (3) 34 (2)
Fermanagh 78 (4) 250 (3) 147 (8) 268 (11)** 102 (22) 90 (4) 87 (7)
Dungannon 98 (4) 307 (3) 148 (6) 167 (6) 103 (17) 80 (3) 116 (7)
Craigavon 74 (5) 61 (1) 90 (6) 106 (6) 108 (30) 126 (8) 50 (5)
Armagh 43 (2) 90 (1) 64 (3) 75 (3) 110 (21) 70 (3) 116 (8)
Newry &
Moume 165 (12) 0 (0) 42 (3) 105 (7) 90 (26) 132 (9) 115 (12)
Banbridge 161 (5) 269 (2) 63 (2) 82 (2) 108 (14) 106 (3) 84 (4)
Down 115 (6) 323 (4)* 76 (4) 67 (3) 126 (27) 105 (5) 77 (6)
Lisbum 126 (11) 47 (1) 85 (7) 120 (9) 109 (38) 84 (7) 89 (11)
Antrim 53 (2) 0 (0) 86 (3) 123 (4) 118 (18) 106 (4) 75 (4)
Newtownabbey 128 (9) 0 (0) 58 (4) 97 (5) 79 (23) 78 (5) 104 (11)
Caffickfergus 133 (4) 272 (2) 67 (2) 170 (4) 104 (13) 143 (4) 67 (3)
North Down 126 (9) 118 (2) 113 (9) 148 (7) 77 (24) 83 (5) 86 (10)
Ards 97 (6) 135 (2) 123 (8) 67 (3) 87 (23) 73 (4) 187 (18)**
Castlereagh 46 (3) 194 (3) 125 (9) 76 (3) 78 (22) 167 (9) 38 (4)*
Belfast 98 (28) 61 (4) 116 (37) 96 (19) 114 (139) 87 (21) 117 (54)
* p<0.05
**p<0.01
male predominance in the 20-50 year olds, and
roughly equal rates in the over 50's, with a slow
increase with age. There is no evidence of an
increase with time. There is no evidence for
between-district heterogeneity from the male and
female SMR's, but possible evidence from the
pooled SMR's (p=0.065 - Table II). In particular,
Down has a significantly raised pooled SMR
(p=0.05), andDungannonhasasignificantlyraised
male SMR (p=0.02). However, these observations
should be treated with caution, owing to the small
number ofcases.
The male shrunk RR's were much more
heterogeneous than the female RR's. Highestrates
occurred in Fermanagh, Dungannon, Banbridge,
Down, Castlereagh, Carrickfergus and Limavady,
whilst very low shrunk RR's were observed for
Ballymena, Newtownabbey, Belfast and Newry
and Mourne. The smoothed RR's were in general
agreement with the shrunk RR's, particularly
concerning the highest rates. However, the lowest
ratesappeartobeconcentratedintwodistinctareas
- the North East of the province and the Mourne
region.
MYELODYSPLASIA
There were 151 cases (Table I). There is a marked
predominance of males aged over 55, but below
thisaslightexcessoffemales. Thereisnoevidence
of a time trend. There is marginal evidence for
between-district heterogeneity from the SMR's
(p=0.086 for pooled; p=O. 10 for males; and
p=0.097 for females). In particular, Omagh has a
raised pooled SMR (p=0.03 - Table II) and Derry
has a raised male SMR (p=0.05). As expected the
smoothed RR's show far more variability than the
shrunkRR's.Thisisparticularly obviousformales.
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Fig 1. Age - specific incidence rates/100,000 population
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There is a strong tendency for the highest rates to
occur in the west of the province and the area
comprisingBelfastandtheArds/Strangford region.
Lowest rates are observed in the North East and
South East of Northern Ireland.
ACUTE LYMPHOBLASTIC LEUKAEMIA
There were 1 17 cases. The age-specific incidence
rates show peaks in the first age quinquennium
(Figure I and Table I). Subsequently there is a
slight male excess in the under 50's and a female
excess in the over 50's with a female peak around
70. There is no evidence ofan increase with time.
Thereisasignificantstatisticalinteractionbetween
sex and geographical distribution at district level
(p=0.007). This indicates that the sex ratio ofrates
varies geographically. There is also marginal
evidence for a statistical interaction between age
and geographical distribution at district level
(p=O.062).Thereisnoevidenceforbetween-district
heterogeneity from either the pooled or female
SMR's.However,thereisstrongvariabilitybetween
districts for males (p=0.01 1).
Fermanagh andNorthDownbothhaveraisedmale
SMR's (p=0.0007 and 0.020 respectively).
Fermanagh has a raised pooled SMR (p=0.005),
due to the excess of male cases (Table II).
Since there is a significant statistical interaction
betweensexandgeographicaldistributionatdistrict
level, the maps of pooled rates may not be
meaningful. Also, because there may be an
interaction between age and geographical
distribution, the male and female maps have to be
treated with caution. (Accordingly, we only
illustrate maps ofmale rates). These maps ofmale
rates are illustrated (Maps I & 2) and show highest
rates in the South West, particularly in County
Fermanagh, and south of Lough Neagh, but also
around Belfast Lough. Lowest rates are seen in the
North and West ofthe province.
NON-HODGKIN'S LYMPHOMA
The study reports on 611 cases. Incidence is low in
children but the incidence rates rise steeply from
earlyadultlife (TableI). Thereisasuggestionofan
adolescentpeakin males. There is amaleexcess at
mostages. Thereisnoevidenceofanincreaseover
time. Surprisingly, in view of English data
suggestingthereverse(McNallyetal-unpublished
observations) there is some suggestion of a male
decrease (p=0.036) over time.
There is no evidence for between-district
heterogeneity in the SMR's (Table II). However,
Belfast appears to have a raised SMR for males
(p=0.048). Neitherthe shrunk RR's northe female
or pooled smoothed RR's show much variability.
The male smoothed RR's show greatervariability,
the highest being observed in Belfast.
HODGKIN'S DISEASE
There were 133 cases of this condition. The age
specific incidence curve shows a peak in young
adults (Table I). Afterthe modal values, which are
similar in both sexes, there is a marked male
predominanceinolderpersonsuptoage75.Forthe
age group 75-79, there is a female excess. There is
no evidence for a time trend.
There is no evidence for between-district
heterogeneity in the SMR's (Table II). However,
Ballymoney appears to have a raised SMR for
females (p=0.04). There is not much variability in
TABLE III
MULTIPLE MYELOMA
Temporal variations (%) in standardised incidence rates
MALE FEMALE POOLED
Year Rate (%) Rate (%) Rate (%)
1989 5.4 (91.1) 3.8 (92.5) 4.4 (90.1)
1990 5.6 (95.0) 5.1 (124.3) 5.3 (109.7)
1991 5.7 (95.6) 4.8 (116.1) 5.2 (107.6)
1992 6.2 (104.4) 2.9 (70.1) 4.2 (86.5)
1993 6.8 (114.1) 4.0 (97.1) 5.2 (106.0)
Test for linear trend: p=0.0141 p=0.5812 p=0.8374
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Map I ACUTE LYMPHOBLASTIC LEUKAEMIA
Incidence ofdisease (shrunk RRs) by district ofresidence. (Male)
RRs 3 ~~80
"' 95 105 120 E RRsT I
NORTHERN IRELAND Local Government Districts.
© The Ulster Medical Society, 1996.
26Leukaemia and Lymphoma
Map 2 ACUTE LYMPHOBLASTIC LEUKAEMIA
Incidence ofdisease (smoothed RRs) by district ofresidence. (Male)
RRs: 3 80 95
/ 105 120
NORTHERN IRELAND Local Government Districts.
C The Ulster Medical Society, 1996.
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Map 3 MULTIPLE MYELOMA
Incidence ofdisease (smoothed RRs) by district ofresidence. (Male)
RRs: 80 95 105 120
NORTHERN IRELAND Local Government Districts.
() The Ulster Medical Society, 1996.
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Map 4 MULTIPLE MYELOMA
Incidence ofdisease (shrunk RRs) by district ofresidence. (Female)
7ZP
RRs: C 80 / 95 105 120
NORTHERN IRELAND Local Government Districts.
C) The Ulster Medical Society, 1996.
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theshrunkRR's. Noclearpatternemergesfromthe
smoothedRR's. Thehighestfemale rates areinthe
North West and Moume area. The highest male
rates are in Castlereagh, Carrickfergus and
Coleraine.
MULTIPLE MYELOMA
There were 224 cases. The disease is absent in
children and young adults, but from the age of 30
onwards there is a steep rise with a marked excess
in males over 60 (Figure 2 and Table I). There is
evidenceforanincreaseinthemalerates (p=0.01),
but the female rates were stable over the 5 year
period (Table III).
There is a problem with under-registration of
multiplemyeloma, andsoincidenceratesarelikely
to be underestimates ofthe true rates.
There is no evidence for between-district
heterogeneityfromeitherthepooledormaleSMR's.
However, there is some evidence (p=0.083) of
heterogeneity amongst the female SMR's. Ards
has a raised pooled SMR (p=0.01 - Table II). The
highest shrunk RR's occurred in the Belfast and
Ards/Strangford areas. High smoothed RR's for
males are observed in the Ards/Strangford area,
and the Mourne district (Map 3). There were very
low female smoothed RR's in the Armagh/South
Down area (Map 4).
CONCLUSIONS
The authors regard this study as an important but
initial step towards a careful and considered
understanding of rates of disease in Northern
Ireland. These early results will be supplemented
by furtherworkbutthey donotshowunusual rates
nor generate any major cause for concern. Indeed
the results are quite similar to those from England
andWales.1Theratesfortheleukaemiasexceptfor
ALL are slightly lowerthan in England andWales
whilst NHL rates are higher.
Possible under-enumeration in the census would
affect district SMR's much more than overall
province-wide age-specific incidence rates. This
wouldhavetheconsequenceofartefactuallyraising
SMR's in under-enumerated districts, and raising
age-specific incidence rates in under-enumerated
agegroups. Inparticulartheanalysisof35 casesof
CMLmustbetreatedwithcaution.Themoststriking
observation istheraisedrates forALLformales in
County Fermanagh. This requires further
investigation and explanation. The Podar report2
examined the hypothesis that leukaemia incidence
and mortality rates were higher in coastal than in
inland areas of Northern Ireland. No significant
coastal excesses were found.
Thebenefitsofthedatacollectionexercisearetwo-
fold.Forthefirsttime,reasonablyreliableestimates
ofthe incidence oftheleukaemias andlymphomas
are available for Northern Ireland by age-group
and local government district. These may be used
in the planning ofhealth services and may also be
very useful in detecting any future excess
occurrences of particular types of leukaemia and
lymphoma.
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